Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Modular Medical, Inc.MODD · Entity 7488 | Chief Operating Officer | May 14, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Modular Medical, Inc.
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $3.46 · Expires 2036-05-14 | Direct | 4,674 |
Reported balance
After 2026-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 4,674 · Balance 4,674 F1: This option shall vest as to 1/3rd of the shares subject to the option on May 14, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter. F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest as to 1/3rd of the shares subject to the option on May 14, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.
F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 18, 2026 22:03 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 4,674 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001213900-26-058599 · ownership.xml · derivative · entry 1 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,674 Underlying: Common Stock · 4,674 shares Expires 2036-05-14 F1 · security: This option shall vest as to 1/3rd of the shares subject to the option on May 14, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter. F1 · derivative.exercise_date: This option shall vest as to 1/3rd of the shares subject to the option on May 14, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 21:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 50,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001213900-25-036213 · ownership.xml · derivative · entry 2 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-04-24 F1 · security: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of U.S. Food and Drug Administration clearance of the 510(K) premarket submission for its MODDi pump product on or before October 31, 2025. If notification is not received on or before that date, the Option will not vest as to any of the shares subject to the option and will terminate on November 1, 2025. F3 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant's manufacturing line has been validated on or before March 15, 2026 for the MODDi pump product with the capacity to produce a supply of product to serve 6,000 patients. If validation does not occur on or before that date, the option will not vest as to any of the shares subject to the option and will terminate on March 16, 2026. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 21:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 50,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001213900-25-036213 · ownership.xml · derivative · entry 1 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-04-24 F1 · security: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of U.S. Food and Drug Administration clearance of the 510(K) premarket submission for its MODDi pump product on or before October 31, 2025. If notification is not received on or before that date, the Option will not vest as to any of the shares subject to the option and will terminate on November 1, 2025. F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of U.S. Food and Drug Administration clearance of the 510(K) premarket submission for its MODDi pump product on or before October 31, 2025. If notification is not received on or before that date, the Option will not vest as to any of the shares subject to the option and will terminate on November 1, 2025. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 21:55 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 24,400 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001213900-24-072660 · ownership.xml · derivative · entry 1 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-08-22 F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) pre-market submission for the Registrant's initial pump product on or before December 31, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on January 1, 2025. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| April 08, 2024 Filed Apr 9, 2024 23:28 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 50,000 | $1.52 Strike: $1.52 | $76,000.00 |
DisclosureSEC source: 0001213900-24-031683 · ownership.xml · derivative · entry 1 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-04-08 F1 · security: This option shall vest as to 1/3rd of the shares subject to the option on April 8, 2025 and as to 1/36th of the shares subject to the option on a monthly basis thereafter. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 18,769 | $1.11 Strike: $1.11 | $20,833.59 |
DisclosureSEC source: 0001013762-23-001575 · ownership.xml · derivative · entry 2 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,769 Underlying: Common Stock · 18,769 shares Expires 2033-10-02 F1 · security: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024. F3 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) premarket submission on or before August 1, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on August 2, 2024. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 37,538 | $1.11 Strike: $1.11 | $41,667.18 |
DisclosureSEC source: 0001013762-23-001575 · ownership.xml · derivative · entry 1 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,538 Underlying: Common Stock · 37,538 shares Expires 2033-10-02 F1 · security: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024. F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:02 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 100,000 | $1.50 Strike: $1.50 | $150,000.00 |
DisclosureSEC source: 0001213900-23-027642 · ownership.xml · derivative · entry 1 Schmid Kevin · CIK 0001395775 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-04-03 F1 · security: This option shall vest as to 1/3rd of the shares subject to the option on April 3, 2024 and as to 1/36th of the shares subject to the option on a monthly basis thereafter. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.